wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34640332-3FF10688-BCC9-43D2-8497-6A488FDF1C86
Q34640332-3FF10688-BCC9-43D2-8497-6A488FDF1C86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34640332-3FF10688-BCC9-43D2-8497-6A488FDF1C86
Eosinophilic gastrointestinal diseases: review and update
P2860
Q34640332-3FF10688-BCC9-43D2-8497-6A488FDF1C86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34640332-3FF10688-BCC9-43D2-8497-6A488FDF1C86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dcec30c2f587f8055b7f964989f17d1804748000
P2860
Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.